Advertisement
Advertisement

SABS

SABS logo

SAB Biotherapeutics, Inc. Common Stock

3.90
USD
Sponsored
+0.05
+1.30%
Aug 07, 15:58 UTC -4
Closed
exchange

After-Market

3.87

-0.03
-0.77%

SAB Biotherapeutics, Inc. Common Stock Profile

About

SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.

Info & Links

CEO

Samuel J. Reich

Headquarters

777 W 41st St, Suite 401
Miami Beach, FL 33140, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.sab.bio

Auditor

EisnerAmper LLP

Share holders

253

Employees

86

SAB Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

352.12M

Enterprise Value

347.05M

Enterprise Value/EBITDA(ttm)

-5.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.30

Price to Cash(ytd)

11.41

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-7.05%

Return on Invested Capital(ttm)

-2.41%

Return on Assets(ttm)

-6.34%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-68.80M

Net Income Available to Common(ttm)

-21.79M

Diluted EPS(ttm)

-1.30

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

77.27%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

90.99M

Dividend Yield

0.00%

Float4

70.81M

% Held by Insiders

7.39%

% Held by Institutions

7.82%

Balance Sheet

Total Cash(mrq)

102.63M

Total Cash Per Share(mrq)

1.13

Total Debt(mrq)

3.20M

Total Debt/Equity(mrq)

1.49%

Current Ratio(mrq)

9.22%

Quick Ratio(mrq)

11.45%

Book Value Per Share(mrq)

2.57

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.30

Free Cash Flow(ytd)

-26.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement